Mayén-Lobo, Y.G.; MartÃnez-Magaña, J.J.; Pérez-Aldana, B.E.; Ortega-Vázquez, A.; Genis-Mendoza, A.D.; Dávila-Ortiz de Montellano, D.J.; Soto-Reyes, E.; Nicolini, H.; López-López, M.; Monroy-Jaramillo, N.
Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis. Pharmaceuticals 2021, 14, 118.
https://doi.org/10.3390/ph14020118
AMA Style
Mayén-Lobo YG, MartÃnez-Magaña JJ, Pérez-Aldana BE, Ortega-Vázquez A, Genis-Mendoza AD, Dávila-Ortiz de Montellano DJ, Soto-Reyes E, Nicolini H, López-López M, Monroy-Jaramillo N.
Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis. Pharmaceuticals. 2021; 14(2):118.
https://doi.org/10.3390/ph14020118
Chicago/Turabian Style
Mayén-Lobo, Yerye Gibrán, José Jaime MartÃnez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Alma Delia Genis-Mendoza, David José Dávila-Ortiz de Montellano, Ernesto Soto-Reyes, Humberto Nicolini, Marisol López-López, and Nancy Monroy-Jaramillo.
2021. "Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis" Pharmaceuticals 14, no. 2: 118.
https://doi.org/10.3390/ph14020118
APA Style
Mayén-Lobo, Y. G., MartÃnez-Magaña, J. J., Pérez-Aldana, B. E., Ortega-Vázquez, A., Genis-Mendoza, A. D., Dávila-Ortiz de Montellano, D. J., Soto-Reyes, E., Nicolini, H., López-López, M., & Monroy-Jaramillo, N.
(2021). Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis. Pharmaceuticals, 14(2), 118.
https://doi.org/10.3390/ph14020118
